Exchange: XETRA Sector: Healthcare Industry: Biotechnology
0.00% €0.245
Europe/Berlin / 30 sep 2022 @ 17:36
FUNDAMENTALS | |
---|---|
MarketCap: | 6.55 mill |
EPS: | -0.555 |
P/E: | -0.440 |
Earnings Date: | N/A |
SharesOutstanding: | 26.72 mill |
Avg Daily Volume: | 0.0080 mill |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/21 | 2/21 | 3/21 | 4/21 | 1/22 | 2/22 | |
Revenue | n/a | n/a | ||||
Gr.Profit | n/a | n/a | ||||
Ebit | n/a | |||||
Asset | n/a | n/a | n/a | n/a | n/a | n/a |
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.440 | sector: PE 19.58 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.03x |
Company: PE -0.440 | industry: PE 15.90 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
€ 0.197 - 0.293 ( +/- 19.59%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | €0.245 (0.00% ) |
Volume | 0.0313 mill |
Avg. Vol. | 0.0080 mill |
% of Avg. Vol | 389.96 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
co.don AG, a biopharmaceutical company, develops, produces, and markets cell-based pharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three dimensional chondrocyte product that is used to treat cartilage defects in adult knee joints; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, shoulder and elbow, and knees of younger patients. The company serves accident and orthopedic surgeons. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.